Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Access Consortium regulators pledge support to tackle COVID-19 The Access Consortium regulatory authorities Footnote 1 have pledged our collective support in countering the COVID-19 global pandemic. To address this worldwide public health crisis, Access Consortium members are…
Joint Statement on Clinical Trial Oversight in Canada Health Canada - Canadian Institutes of Health Research - Canadian Association of Research Ethics Boards Published: May 27, 2020 Health Canada (HC) and the Canadian Institutes of Health Research (CIHR), with the collaboration…
Depuis mars 2020, les IRSC ont investi environ 414 millions de dollars dans 965 projets de recherche sur la COVID-19.
ARCHIVED Applications for COVID-19 drug and medical device clinical trials under the Interim Order: Notice release of guidance documents Notice to Reader: We have replaced the Interim Order No. 2 respecting clinical trials for medical devices and drugs relating to COVID-19. See…
ARCHIVED Interim Order respecting clinical trials for medical devices and drugs relating to COVID-19: Notice Notice to Reader: We have replaced the Interim Order No. 2 respecting clinical trials for medical devices and drugs relating to COVID-19. See the regulations notice about…
Changes to notification requirements for biologic drugs: Notice to industry Health Canada is reducing the administrative burden to help clinical trial sponsors and market authorization holders efficiently distribute treatments. On this page Purpose and background Measures to…
Prescription Drug List (PDL): Remdesivir (COVID-19) notice Date published: July 28, 2020 Our file number: 20-110364-67 The purpose of this Notice of Amendment is to notify about the addition of remdesivir to the Prescription Drug List (PDL) for human and veterinary use. The new…
Order to extend review period for clinical trial applications and amendments: Notice Date published: August 14, 2020 On August 13, 2020, the Minister of Health approved an order to temporarily extend the default period to review clinical trial applications and amendments . This…
ARCHIVED Interim order and guidance document to import, sell and advertise COVID-19 related drugs and vaccines: Notice COVID-19 drugs that were authorized in Canada under the Interim order respecting the importation, sale and advertising of drugs for use in relation to COVID-19…
Archived: Public release of clinical information for drugs and medical devices in COVID-19 interim orders applications: Guidance On February 22, 2023, Health Canada introduced the Regulations Amending the Medical Devices Regulations (Interim Order No. 3 Respecting the Importation…
Early release: coverage and features are still expanding.
